EMA QA Document for the Implementation of the Variations Guidelines

Recommendation
14/15 October 2025
With updates on the CEP 2.0!
The European Medicines Agency (EMA) has published a document with practical questions and answers to support the implementation of the variations guidelines in the centralised procedure. The Q&A Document provides practical considerations concerning the implementation of the various categories of variations, on the operation of the respective procedures and on the documentation to be submitted pursuant to those procedures (the 'variations guidelines')
The questions are organised into the following themes:
- general consideration
- new classification category C.1.11
- new classification category C.1.13
- impact on post-authorisation measure (PAM) submissions
- revised classification category C.I.8
- new classification category A.8
Source: EMA/427505/2013 Rev.1
Related GMP News
25.06.2025Is Knowledge Management a Part of the Pharmaceutical Quality System?
11.06.2025Swissmedic differentiates GMP Scope for Manufacturing and Preparation for Administration
28.05.2025A View on the EU Critical Medicines Act to secure Pharma Supply Chains
20.05.2025Summary Data on Registration and Listing of Cosmetic Facilities and Products
07.05.2025FDA is extending its Quality Management Maturity Programme
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review